Document is current
Any future updates will be listed below
-
Authors
Endres, Dominique https://orcid.org/0000-0001-7322-1195
von Zedtwitz, Katharina
Urbach, Horst
Dersch, Rick
Runge, Kimon https://orcid.org/0000-0002-0263-4360
Feige, Bernd https://orcid.org/0000-0002-9436-1258
Nickel, Kathrin https://orcid.org/0000-0001-9863-317X
Schiele, Miriam A.
Prüss, Harald https://orcid.org/0000-0002-8283-7976
Domschke, Katharina https://orcid.org/0000-0002-2550-9132
Reisert, Marco
Coenen, Volker A. https://orcid.org/0000-0002-1703-6283
- License Information
-
More Information
Article History
Received: 10 September 2022
Revised: 15 October 2022
Accepted: 21 October 2022
First Online: 10 November 2022
Competing interests
: RD: Lecture fees from Roche, Alexion, Bayer, and Sanofi. Travel grant from Biogen. KD: Steering Committee Neurosciences, Janssen. Speaker fees from Janssen. VAC: Consultation work for CereGate (Munich, Germany), Cortec (Freiburg, Germany), and Inbrain (Barcelona, Spain). Honoraria for Talks (Boston Scientific, USA). IITs in DBS with Medtronic (USA) and Boston Scientific (USA). All other authors declare no potential competing interests.
: Both patients have given her signed written informed consent for this cumulative case study to be published.
